Similar pattern of peripheral neuropathy in mouse models of type 1 diabetes and Alzheimer's disease

Neuroscience

Volumn 202, Issue , 2012, Pages 405-412

  Jolivalt, C G ^a   Calcutt, N A ^a   Masliah, E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Amyloid precursor protein; Diabetes; Diabetic neuropathy; Insulin signaling; Sciatic nerve

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3BETA; INSULIN; INSULIN RECEPTOR;

AGED; ALZHEIMER DISEASE; ANESTHESIA (SENSORY DYSFUNCTION); ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BODY WEIGHT; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC NEUROPATHY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GLUCOSE BLOOD LEVEL; HYPOALGESIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; LOSS OF TACTILE SENSITIVITY; MOTOR NERVE CONDUCTION; MOUSE; NERVE CONDUCTION DISORDER; NONHUMAN; PERIPHERAL NEUROPATHY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SCIATIC NERVE; SIGNAL TRANSDUCTION; TACTILE DISCRIMINATION; THERMAL HYPOALGESIA; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BLOTTING, WESTERN; BRAIN CHEMISTRY; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; GLYCOGEN SYNTHASE KINASE 3; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, TRANSGENIC; NEURAL CONDUCTION; PERIPHERAL NERVOUS SYSTEM DISEASES; PHOSPHORYLATION; SCIATIC NEUROPATHY; SENSORY THRESHOLDS; THERMOSENSING; TOUCH; UBIQUITIN THIOLESTERASE;

EID: 84856210604     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.11.032     Document Type: Article

References (55)

1. Beiswenger K.K., Calcutt N.A., Mizisin A.P. Dissociation of thermal hypoalgesia and epidermal denervation in streptozotocin-diabetic mice. Neurosci Lett 2008, 442:267-272.
2. Belin C., Gatt M.T. Pain and dementia [Article in French]. Psychol Neuropsychiatr Vieil 2006, 4:247-254.
3. Biessels G.J., Deary I.J., Ryan C.M. Cognition and diabetes: a lifespan perspective. Lancet Neurol 2008, 7:184-190.
4. Brussee V., Cunningham F.A., Zochodne D.W. Direct insulin signaling of neurons reverses diabetic neuropathy. Diabetes 2004, 53:1824-1830.
5. Calcutt N.A. Modeling diabetic sensory neuropathy in rats. Methods Mol Med 2004, 99:55-65.
6. Calcutt N.A., Chaplan S.R. Spinal pharmacology of tactile allodynia in diabetic rats. Br J Pharmacol 1997, 122:1478-1482.
7. Calcutt N.A., Jolivalt C.G., Fernyhough P. Growth factors as therapeutics for diabetic neuropathy. Curr Drug Targets 2008, 9:47-59.
8. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994, 53:55-63.
9. Christianson J.A., Ryals J.M., Johnson M.S., Dobrowsky R.T., Wright D.E. Neurotrophic modulation of myelinated cutaneous innervation and mechanical sensory loss in diabetic mice. Neuroscience 2007, 145:303-313.
10. Christianson J.A., Ryals J.M., McCarson K.E., Wright D.E. Beneficial actions of neurotrophin treatment on diabetes-induced hypoalgesia in mice. J Pain 2003, 4:493-504.
11. Cukierman T., Gerstein H.C., Williamson J.D. Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies. Diabetologia 2005, 48:2460-2469.
12. Desrocher M., Rovet J. Neurocognitive correlates of type 1 diabetes mellitus in childhood. Child Neuropsychol 2004, 10:36-52.
13. Dineley K.T., Hogan D., Zhang W.R., Taglialatela G. Acute inhibition of calcineurin restores associative learning and memory in Tg2576 APP transgenic mice. Neurobiol Learn Mem 2007, 88:217-224.
14. Dineley K.T., Kayed R., Neugebauer V., Fu Y., Zhang W., Reese L.C., Taglialatela G. Amyloid-beta oligomers impair fear conditioned memory in a calcineurin-dependent fashion in mice. J Neurosci Res 2010, 88:2923-2932.
15. Dixon W.J. Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 1980, 20:441-462.
16. Fernyhough P., Willars G.B., Lindsay R.M., Tomlinson D.R. Insulin and insulin-like growth factor I enhance regeneration in cultured adult rat sensory neurones. Brain Res 1993, 607:117-124.
17. Greene D.A., Stevens M.J., Feldman E.L. Diabetic neuropathy: scope of the syndrome. Am J Med 1999, 107:2S-8S.
18. Guo G., Kan M., Martinez J.A., Zochodne D.W. Local insulin and the rapid regrowth of diabetic epidermal axons. Neurobiol Dis 2011, 43:414-421.
19. Huang T.J., Verkhratsky A., Fernyhough P. Insulin enhances mitochondrial inner membrane potential and increases ATP levels through phosphoinositide 3-kinase in adult sensory neurons. Mol Cell Neurosci 2005, 28:42-54.
20. Joachim C.L., Mori H., Selkoe D.J. Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease. Nature 1989, 341:226-230.
21. Johnson M.S., Ryals J.M., Wright D.E. Early loss of peptidergic intraepidermal nerve fibers in an STZ-induced mouse model of insensate diabetic neuropathy. Pain 2008, 140:35-47.
22. Jolivalt C.G., Hurford R., Lee C.A., Dumaop W., Rockenstein E., Masliah E. Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice. Exp Neurol 2010, 223:422-431.
23. Jolivalt C.G., Lee C.A., Beiswenger K.K., Smith J.L., Orlov M., Torrance M.A., Masliah E. Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer's disease and correction by insulin. J Neurosci Res 2008, 86:3265-3274.
24. Jope R.S., Johnson G.V. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 2004, 29:95-102.
25. Kasa P., Papp H., Kovacs I., Forgon M., Penke B., Yamaguchi H. Human amyloid-beta1-42 applied in vivo inhibits the fast axonal transport of proteins in the sciatic nerve of rat. Neurosci Lett 2000, 278:117-119.
26. Leibson C.L., Rocca W.A., Hanson V.A., Cha R., Kokmen E., O'Brien P.C., Palumbo P.J. Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am J Epidemiol 1997, 145:301-308.
27. Li Q., Fang J., Yang M., Wu D., Zhang L., Zhang Y. Galantamine inhibits calpain-calcineurin signaling activated by beta-amyloid in human neuroblastoma SH-SY5Y cells. Neurosci Lett 2010, 480:173-177.
28. Manschot S.M., Brands A.M., van der Grond J., Kessels R.P., Algra A., Kappelle L.J., Biessels G.J. Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes 2006, 55:1106-1113.
29. McCarthy A.M., Lindgren S., Mengeling M.A., Tsalikian E., Engvall J.C. Effects of diabetes on learning in children. Pediatrics 2002, 109:E9.
30. McGowan E., Eriksen J., Hutton M. A decade of modeling Alzheimer's disease in transgenic mice. Trends Genet 2006, 22:281-289.
31. McGuire J.F., Rouen S., Siegfreid E., Wright D.E., Dobrowsky R.T. Caveolin-1 and altered neuregulin signaling contribute to the pathophysiological progression of diabetic peripheral neuropathy. Diabetes 2009, 58:2677-2686.
32. Obrosova I.G. Diabetic painful and insensate neuropathy: pathogenesis and potential treatments. Neurotherapeutics 2009, 6:638-647.
33. Ott A., Stolk R.P., Hofman A., van Harskamp F., Grobbee D.E., Breteler M.M. Association of diabetes mellitus and dementia: the Rotterdam study. Diabetologia 1996, 39:1392-1397.
34. Papp H., Pakaski M., Kasa P. Presenilin-1 and the amyloid precursor protein are transported bidirectionally in the sciatic nerve of adult rat. Neurochem Int 2002, 41:429-435.
35. Pedersen W.A., Flynn E.R. Insulin resistance contributes to aberrant stress responses in the Tg2576 mouse model of Alzheimer's disease. Neurobiol Dis 2004, 17:500-506.
36. Peila R., Rodriguez B.L., Launer L.J. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia aging study. Diabetes 2002, 51:1256-1262.
37. Reaven G.M., Thompson L.W., Nahum D., Haskins E. Relationship between hyperglycemia and cognitive function in older NIDDM patients. Diabetes Care 1990, 13:16-21.
38. Rockenstein E., Mallory M., Mante M., Sisk A., Masliah E. Early formation of mature amyloid-beta proteins deposits in a mutant APP transgenic model depends on levels of Abeta(1-42). J Neurosci Res 2001, 66:573-582.
39. Rönnemaa E., Zethelius B., Sundelöf J., Sundström J., Degerman-Gunnarsson M., Lannfelt L., Berne C., Kilander L. Glucose metabolism and the risk of Alzheimer's disease and dementia: a population-based 12 year follow-up study in 71-year-old men. Diabetologia 2009, 52:1504-1510.
40. Ryan C., Vega A., Drash A. Cognitive deficits in adolescents who developed diabetes early in life. Pediatrics 1985, 75:921-927.
41. Ryan C.M., Williams T.M. Effects of insulin-dependent diabetes on learning and memory efficiency in adults. J Clin Exp Neuropsychol 1993, 15:685-700.
42. Scherder E., van Manen F. Pain in Alzheimer's disease: nursing assistants' and patients' evaluations. J Adv Nurs 2005, 52:151-158.
43. Scherder E.J., Oosterman J.M., Ooms M.E., Ribbe M.W., Swaab D.F. Chronic pain in dementia and in disorders with a high risk for congnitive impairment [Article in Dutch]. Tijdschr Gerontol Geriatr 2005, 36:116-121.
44. Sisodia S.S., Koo E.H., Hoffman P.N., Perry G., Price D.L. Identification and transport of full-length amyloid precursor proteins in rat peripheral nervous system. J Neurosci 1993, 13:3136-3142.
45. Sugimoto K., Murakawa Y., Sima A.A. Expression and localization of insulin receptor in rat dorsal root ganglion and spinal cord. J Peripher Nerv Syst 2002, 7:44-53.
46. Sugimoto K., Murakawa Y., Zhang W., Xu G., Sima A.A. Insulin receptor in rat peripheral nerve: its localization and alternatively spliced isoforms. Diabetes Metab Res Rev 2000, 16:354-363.
47. Takashima A., Yamaguchi H., Noguchi K., Michel G., Ishiguro K., Sato K., Hoshino T., Hoshi M., Imahori K. Amyloid beta peptide induces cytoplasmic accumulation of amyloid protein precursor via tau protein kinase I/glycogen synthase kinase-3 beta in rat hippocampal neurons. Neurosci Lett 1995, 198:83-86.
48. Terry R.D. Alzheimer's disease and the aging brain. J Geriatr Psychiatry Neurol 2006, 19:125-128.
49. Thomas P.K. Classification, differential diagnosis, and staging of diabetic peripheral neuropathy. Diabetes 1997, 46(Suppl 2):S54-S57.
50. Toth C.C., Jedrzejewski N.M., Ellis C.L., Frey W.H. Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain. Mol Pain 2010, 6:16.
51. Valente T., Gella A., Fernàndez-Busquets X., Unzeta M., Durany N. Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus. Neurobiol Dis 2010, 37:67-76.
52. Velayudhan L., Poppe M., Archer N., Proitsi P., Brown R.G., Lovestone S. Risk of developing dementia in people with diabetes and mild cognitive impairment. Br J Psychiatry 2010, 196:36-40.
53. Xu W.L., von Strauss E., Qiu C.X., Winblad B., Fratiglioni L. Uncontrolled diabetes increases the risk of Alzheimer's disease: a population-based cohort study. Diabetologia 2009, 52:1031-1039.
54. Yasuda H., Terada M., Maeda K., Kogawa S., Sanada M., Haneda M., Kashiwagi A., Kikkawa R. Diabetic neuropathy and nerve regeneration. Prog Neurobiol 2003, 69:229-285.
55. Yoshitake T., Kiyohara Y., Kato I., Ohmura T., Iwamoto H., Nakayama K., Ohmori S., Nomiyama K., Kawano H., Ueda K., et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama study. Neurology 1995, 45:1161-1168.